Focal Segmental Glomerulosclerosis
📧 Sign up to get email alerts when something new happens for Focal Segmental Glomerulosclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Raman Spectroscopy Diagnosis of Kidney Diseases
This update describes an ongoing clinical trial evaluating Raman spectroscopy as a diagnostic tool for kidney diseases, including IgA nephro…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure
ClinicalTrials.gov update describes a study on genetic causes of focal segmental glomerulosclerosis, nephrotic syndrome, and related kidney …
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects [Phase 1]
First-in-human Phase 1 trial to evaluate safety, tolerability, and pharmacology of HS-10390 in healthy subjects; the study lists IgA nephrop…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1
Clinical trial update investigating predictive determinants of nephrotic syndrome remission in patients with at-risk APOL1 polymorphisms, in…
-
CLINICAL_TRIALS research · 2017-06-20Clinical Trial Update: Valproic Acid for Idiopathic Nephrotic Syndrome [Phase 2, Phase 3]
Clinical trial update on valproic acid for idiopathic nephrotic syndrome, with Phase 2 and Phase 3, including mention of focal segmental glo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.